Michelle Khine is a professor of biomedical engineering, Director of Faculty Innovation, Director of BioENGINE at the Samueli School of Engineering, University of California, Irvine. She was an assistant & founding professor at U.C. Merced from 2006 to 2009. Khine received her B.S. and M.S. from U.C. Berkeley in mechanical engineering in 19999 and 20001 respectively. She earned her Ph.D., under Luke P. Lee, in bioengineering at U.C. Berkeley and U.C. San Francisco in 2005. She was the scientific founder of Fluxion Biosciences, Shrink Nanotechnologies, and most recently, Novoheart.